The use of bone age in clinical practice - Part 2

David D. Martin, Jan M. Wit, Ze'Ev Hochberg, Rick R. Van Rijn, Oliver Fricke, George Werther, Noël Cameron, Thomas Hertel, Stefan A. Wudy, Gary Butler, Hans Henrik Thodberg, Gerhard Binder, Michael B. Ranke

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

64 Citaten (Scopus)


If height-limiting treatment is being considered for a child with tall stature, skeletal maturity is invaluable in the selection of appropriate patients for treatment, determining appropriate age of treatment commencement, monitoring progress of treatment, and determining the expected treatment effect on adult height. In precocious puberty, bone maturation can be usefully assessed at initial diagnosis and start of treatment and at regular intervals thereafter during treatment monitoring. Together with height, bone maturation is an essential parameter for long-term treatment monitoring in congenital adrenal hyperplasia. Bone age (BA) determination in children with skeletal dysplasia is only feasible in a few disorders and estimations should be treated with caution. Radiographs of the left hand and wrist are, however, essential in the diagnosis of many skeletal disorders. Bone mineralization and measures of bone lengths, width, thickness and cortical thickness should always be evaluated in relation to a child's height and BA, especially around puberty. The use of skeletal maturity, assessed on a radiograph alone to estimate chronological age for immigration authorities or criminal courts is not recommended.

Originele taal-2Engels
Pagina's (van-tot)10-16
Aantal pagina's7
TijdschriftHormone Research in Paediatrics
Nummer van het tijdschrift1
StatusGepubliceerd - jul. 2011
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'The use of bone age in clinical practice - Part 2'. Samen vormen ze een unieke vingerafdruk.

Citeer dit